This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You Looking for a High-Growth Dividend Stock? Colgate-Palmolive (CL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Top Stock Reports for Amazon, Visa, UPS & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com (AMZN), Visa (V) and United Parcel Service (UPS).
Colgate (CL) Q2 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 results reflect strength in North America and Hill's segments as well as robust volume growth and pricing across regions.
Colgate-Palmolive (CL) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.23% and 2.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Colgate-Palmolive (CL)
by Zacks Equity Research
Colgate-Palmolive (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors Shaping the Fate of Church & Dwight (CHD) Q2 Earnings
by Zacks Equity Research
Church & Dwight (CHD) second-quarter earnings results are likely to have gained from coronavirus-induced demand spike for household and personal care products.
Things You Must Know Ahead of AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
Softness in the on-premise channel due to closure of restaurants and bars is expected to have marred AB InBev's (BUD) top line in Q2. E-commerce sales are likely to partly cushion results.
Is Colgate (CL) Poised to Beat Earnings Estimates in Q2?
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 sales are likely to have benefited from investment in brands, favorable pricing strategy, innovative product launches and enhancement of e-commerce capabilities.
Soft On-Premise Sales to Mar Molson Coors' (TAP) Q2 Earnings
by Zacks Equity Research
Molson Coors' (TAP) second-quarter 2020 results are likely to reflect significant impacts from the closure of on-premise sales channels in almost all markets and other headwinds on the global economy.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soap & Cleaning Materials Industry Outlook Bubbling With Optimism
by Rajani Lohia
Escalated demand for hand sanitizers, toilet paper, surface cleaners, disinfecting wipes and other household cleansing essentials are likely to aid Soap & Cleaning Materials players in the near term.
Here's How Hershey (HSY) Looks Ahead of Q2 Earnings Release
by Zacks Equity Research
Hershey's (HSY) second-quarter 2020 results are likely to reflect pricing gains. However, the company's foodservice and travel retail businesses have been affected by COVID-19.
Colgate-Palmolive (CL) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Colgate-Palmolive (CL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Colgate-Palmolive (CL) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
Retirees Should Know These 3 Facts About Required Minimum Distributions - July 17, 2020
by Zacks Equity Research
Like the majority of investors, you're most likely working on a retirement portfolio that will provide a large enough nest egg to give you a comfortable retirement. Make sure you know all about what financial planners call the accumulation and distribution phases of retirement planning.
Factors You Must Watch Before Philip Morris (PM) Q2 Earnings
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2020 results are likely to reflect adverse impacts of coronavirus. The company expects lower duty-free sales and a fall in the rate of new IQOS user acquisition.
Here's Why Church & Dwight (CHD) Appears to be Sparkling
by Zacks Equity Research
Church & Dwight (CHD) has been gaining from burgeoning demand amid the pandemic. Also, the company's focus on innovation and buyouts has been aiding.
Why Colgate Stock Should Remain in Investors' Portfolio
by Zacks Equity Research
Colgate (CL) has been one of the beneficiaries of the rise in demand for everyday essentials amid the pandemic.
Things to Note Ahead of Helen of Troy's (HELE) Q1 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2021 results are likely to reflect gains from Leadership Brands. However, the pandemic is likely to have affected sales.
Clorox (CLX) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Clorox (CLX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Looking for a Growth Stock? 3 Reasons Why Colgate-Palmolive (CL) is a Solid Choice
by Zacks Equity Research
Colgate-Palmolive (CL) possesses solid growth attributes, which could help it handily outperform the market.
Are You Looking for a High-Growth Dividend Stock? Colgate-Palmolive (CL) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes? Let's find out.
3 Investing Facts About Required Minimum Distributions You Need to Know - June 29, 2020
by Zacks Equity Research
Like many investors, you're likely aiming to build a comfortable nest egg to ensure a comfortable retirement. Make sure you know all about what financial planners dub the accumulation and distribution phases of retirement planning.
Buy Clorox (CLX) Stock Now for Coronavirus Volatility and Beyond?
by Benjamin Rains
Clorox shares have surged 35% in 2020 to crush the S&P 500's 5% decline as its disinfectant wipes fly off the shelves during the coronavirus pandemic. With this in mind, investors might want to consider buying CLX stock as coronavirus volatility returns...
Fed Sparks Economic Concerns: Winning Investment Strategies
by Sanghamitra Saha
The Fed now expects the U.S. unemployment rate to hit 9.3% this year and sees American GDP falling by 6.5% in 2020.